Skip to Main Content

Paper Details

Long-Term Efficacy and Safety of Mavacamten in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.
JAMA Cardiol
0
2023
Mavacamten, Obstructive Hypertrophic Cardiomyopathy, Patients
Author NameAffiliation
James E UdelsonTufts Medical Center
James E Udelson
Robert O BonowNorthwestern University Feinberg School of Medicine
Robert O Bonow
Robert O BonowNorthwestern University Feinberg School of Medicine
Robert O Bonow
  • 1 - 6

Datasets

Release 1.2